AHA Cardiovascular Genome Phenome Study – LOI: June 3, 2014
Pathway Grants RFP Now Open!
The Cardiovascular Genome Phenome Study (CVGPS) is a collaborative effort, spearheaded by the American Heart Association (AHA), to accelerate the future of cardiovascular medicine. CVGPS combines the power of long-term population studies with the precision of molecular analysis to unravel key distinctions between and within subgroups of patients. The discoveries it generates will point the way toward better-targeted, safer, and more effective treatments, based on a deeper understanding of patients’ characteristics, including e.g. risk profiles and therapeutic needs.
The CVGPS is a collaboration among AHA, Boston University (BU) and the University of Mississippi Medical Center (UMMC), the academic coordinating center homes, respectively, of the Framingham Heart Study (FHS) and the Jackson Heart Study (JHS). The Jackson Heart Study also involves Jackson State University (JSU) and Tougaloo College (TC) as partner institutions.
Through the rich diversity of constituent participant/patient populations, CVGPS research will bring inter-individual and patient-to-patient differences into ever sharper focus for common diseases such as atherosclerosis and hypertension.
To accomplish the promise of the CVGPS, AHA is offering CVGPS Pathway Grants, which are funded at $250K/year for 2 years for a total of $500K.
The Letter of Application (LOA) for the CVGPS Pathway Grants is now open for application in Grants@Heart. The deadline to submit an LOA for the Pathway Grants is June 3. An LOA is required to ensure responsiveness to the unique nature of these programs. After peer reviewed, only invited applicant proposals will be accepted.
View more details regarding the CVGPS Pathway Grants Letter of Application.
For additional information about the desired characteristics, letter of application and peer review criteria view the full Request for Applications.